SoloPace Announces US Commercial Release of the SOLO PACE FUSION Temporary Pacing System Following FDA 510(k) Clearance

New temporary pacing system is designed to improve patient safety, reduce costs, and enhance efficiency for transcatheter heart valve (THV) procedures. SAN FRANCISCO, March 31, 2026 /PRNewswire/ -- Solo Pace Incorporated, an emerging medical technology company, today announced the...